Lawendy Bishoy, Bhatti Tayyaba, Adekunle Ayooluwatomiwa D, Rubens Muni, Babajide Oyedotun, Sedarous Mary, Tariq Tahniyat, Okafor Philip N
University of Western Ontario, London, Canada.
Division of Internal Medicine, St. Luke's Hospital, Chesterfield, MO, USA.
Dig Dis Sci. 2025 Apr 8. doi: 10.1007/s10620-025-09004-z.
Evidence suggests that outcomes are poorer among patients from historically marginalized racial and ethnic backgrounds. The impact of patient racial and ethnic diversity on gastrointestinal outcomes is understudied.
To investigate the impact of patient racial/ethnic diversity on gastrointestinal disease (GI) outcomes.
Using the 2019 National Inpatient Sample (NIS), hospital inpatient racial/ethnic diversity was defined as the percentage of Hispanic or Native American discharges. We included gastrointestinal bleeding, inflammatory bowel diseases, gastrointestinal obstruction, cirrhosis, and alcohol-associated hepatitis. Logistic regression was used to predict outcomes [major complications (MCC), long length of stay, high total charges], controlling for age, gender, location, income quartile, hospital size, and region.
Our cohort included 537,830 hospitalizations. In the unadjusted analyses, MCC rates were higher among Hispanic (24.8%) and Native American patients (30.4%), compared to Whites (18.3%). In adjusted analyses, compared to Whites, Hispanic [adjusted odds ratio (OR) 1.21, 95% Confidence Interval (CI) 1.15-1.28] and Native American patients [OR 1.25, (95% CI) 1.09-1.43] had higher MCC rates. As hospital Hispanic diversity increased, MCC for Hispanics improved [OR 0.93, (95% CI) 0.87-1.14] and were even better among Native American patients as their diversity increased [OR 0.83, (95% CI) 0.73-0.94] (Table 1). A similar trend was observed in the 2018 validation cohort.
Increasing hospital inpatient Hispanic and Native American diversity is associated with better outcomes for these groups. Further research is needed on the impact cultural competence and linguistic concordance on gastrointestinal outcomes.
有证据表明,来自历史上被边缘化的种族和族裔背景的患者预后较差。患者种族和族裔多样性对胃肠道疾病预后的影响研究不足。
研究患者种族/族裔多样性对胃肠道疾病(GI)预后的影响。
使用2019年全国住院患者样本(NIS),医院住院患者的种族/族裔多样性定义为西班牙裔或美国原住民出院患者的百分比。我们纳入了胃肠道出血、炎症性肠病、胃肠道梗阻、肝硬化和酒精性肝炎。采用逻辑回归预测预后[主要并发症(MCC)、住院时间长、总费用高],并对年龄、性别、地点、收入四分位数、医院规模和地区进行控制。
我们的队列包括537,830例住院病例。在未调整的分析中,西班牙裔(24.8%)和美国原住民患者(30.4%)的MCC发生率高于白人(18.3%)。在调整分析中,与白人相比,西班牙裔患者[调整后的优势比(OR)为1.21,95%置信区间(CI)为1.15-1.28]和美国原住民患者[OR为1.25,(95%CI)为1.09-1.43]的MCC发生率更高。随着医院西班牙裔多样性的增加,西班牙裔患者的MCC有所改善[OR为0.93,(95%CI)为0.87-1.14],而美国原住民患者随着其多样性的增加,MCC改善更为明显[OR为0.83,(95%CI)为0.73-0.94](表1)。在2018年的验证队列中也观察到了类似趋势。
医院住院患者中西班牙裔和美国原住民多样性的增加与这些群体更好的预后相关。需要进一步研究文化能力和语言一致性对胃肠道疾病预后的影响。